DR. CHRIS BAKER

WOODLANDS MEDICAL SPECIALISTS
Department of Radiation Oncology

RESIDENCY
Residency in Radiation Oncology
Huntsman Cancer Institute, University of Utah School of Medicine
Salt Lake City, Utah
Chief Resident

INTERNSHIP
Transitional Year
Brookwood Baptist Health
Birmingham, Alabama

MEDICAL SCHOOL
Doctorate of Medicine
University of Alabama at Birmingham School of Medicine
Birmingham, Alabama

AFFILIATIONS/ACHIEVEMENTS

  • Florida Licensed
  • Member of the American Society for Radiation Oncology
  • Member of the American Medical Associate

  • Member of University of Alabama Medical Alumni Association

RESEARCH & PUBLICATIONS

  • Poppe MM, Yehia ZA, Baker CB, Goyal S, Toppmeyer D, Kirstein L, Chunxia C, Moore DF, Haffty BG, Khan AJ. 5 year update of a multi-institution prospective phase II hypofractionated post-mastectomy radiation therapy trial. IJROBP. 2020.
  • Baker CB. Triple synchronous multiple primary neoplasms: a case report. Brookwood Baptist Health Research Day, 2017, Birmingham, AL. (Poster Presentation)
  • Bheemanathni S, Baker CB, Younes MA, Ibrahim F. “A rare cause of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.” Southern Hospital Medicine Conference, 2016, New Orleans, LA. (Poster Presentation)
  • Baker CB, McDonald AM, Yang ES, Jacob R, Rais-Bahrami S, Nix J, Fiveash JB. Pelvic radiotherapy versus radical prostatectomy with limited lymph node sampling for high grade prostate adenocarcinoma. Prostate Cancer. 2016.  
  • McDonald AM, Baker CB, Popple RA, Cardan R, Fiveash JB. Increased radiation dose heterogeneity within the prostate predisposes to urethral strictures in patients receiving moderately hypofractionated prostate radiotherapy. Practical Radiation Oncology. 2015, 5:5.
  • Baker CB, McDonald AM, Dulaney C, Clark GM, Yang ES, Jacob R, Fiveash JB. “Treatment outcomes of radiotherapy versus prostatectomy for localized prostate cancer with Gleason 8 or more on biopsy.” American Society of Clinical Oncology Genitourinary Cancer Symposium 2015, Orlando, FL. (Poster Presentation)
  • McDonald AM, Baker CB, Popple RA, Shekar K, Yang ES, Jacob R, Cardan R, Kim RY, Fiveash JB. Different rectal toxicity tolerance with and without simultaneous conventionally-fractionated pelvic lymph node treatment in patients receiving hypofractionated prostate radiotherapy. Radiation Oncology. 2014, 9:129.
  • McDonald AM, Baker CB, Shekar K, Popple RA, Clark GM, Yang ES, Jacob R, Kim RY, Fiveash JB. Reduced radiation tolerance of penile structures associated with dose-escalated hypofractionated prostate radiotherapy. Urology. 2014, 84:6.
  • Baker CB, McDonald AM, Popple RA, Shekar K, Yang ES, Jacob R, Fiveash JB. “Dosimetric predictors of sexual function after external beam radiotherapy for men with prostate cancer.” Poster presentation at University of Alabama School of Medicine Medical Student Research Day 2013.

CONTACT INFORMATION

HOURS

Monday – Friday 8:00 – 5:00

LOCATIONS

NORTH DAVIS